Determination of N-acetylation phenotype using caffeine as a metabolic probe and high-performance liquid chromatography with either ultraviolet detection or electrospray mass spectrometry

被引:13
作者
Baud-Camus, F
Marquet, P
Soursac, M
Davrinche, C
Farinotti, R
机构
[1] Fac Pharm Chatenay Malabry, UPRES 2706, Dept Clin Pharm, F-92296 Chatenay Malabry, France
[2] Hop Univ Dupuytren, Serv Pharmacol & Toxicol, F-87042 Limoges, France
来源
JOURNAL OF CHROMATOGRAPHY B | 2001年 / 760卷 / 01期
关键词
N-acetylation phenotype; caffeine; 1-methylxanthine; 1-methyluric acid; 5-acetylamino-6-amino-3-methyluracil;
D O I
10.1016/S0378-4347(01)00246-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid, sensitive method using liquid chromatography-electrospray mass spectrometry (LC-ES-MS) was developed and evaluated for the simultaneous quantitative determination of caffeine metabolites 1U, 1X and AAMU in human urine. This method involved a simple dilution of urine samples. The chromatographic separation was achieved on a C-18 reversed-phase column using a gradient of acetonitrile in 2 mM, pH 3.0 ammonium formate as mobile phase. After ionisation in an electrospray source, mass spectrometric detection was performed in the negative ion, selected ion monitoring mode. This method yielded acceptable accuracy and precision within the range 0.25-50 mug/ml. This analytical method was applied to investigate the N-acetylator phenotype of HIV infected patients and compared with high-performance liquid chromatography with UV detection. Its specificity was better, which appeared to be absolutely necessary to prevent errors in metabolic ratios and phenotype interpretation. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:55 / 63
页数:9
相关论文
共 16 条
[11]   POTENTIAL ARTIFACTS IN THE USE OF CAFFEINE TO DETERMINE ACETYLATION PHENOTYPE [J].
LORENZO, B ;
REIDENBERG, MM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (02) :207-208
[12]   Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans [J].
Rasmussen, BB ;
Brosen, K .
THERAPEUTIC DRUG MONITORING, 1996, 18 (03) :254-262
[13]   DETERMINATION OF CAFFEINE AND ITS METABOLITES IN URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND CAPILLARY ELECTROPHORESIS [J].
RODOPOULOS, N ;
NORMAN, A .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1994, 54 (04) :305-315
[14]   DETERMINATION OF ACETYLATED CAFFEINE METABOLITES BY HIGH-PERFORMANCE EXCLUSION CHROMATOGRAPHY [J].
TANG, BK ;
ZUBOVITS, T ;
KALOW, W .
JOURNAL OF CHROMATOGRAPHY, 1986, 375 (01) :170-173
[15]   CAFFEINE AS A METABOLIC PROBE - VALIDATION OF ITS USE FOR ACETYLATOR PHENOTYPING [J].
TANG, BK ;
KADAR, D ;
QIAN, L ;
IRIAH, J ;
YIP, J ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (06) :648-657
[16]   A COMPETITIVE ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR THE DETERMINATION OF N-ACETYLTRANSFERASE (NAT2) PHENOTYPES [J].
WONG, P ;
LEYLANDJONES, B ;
WAINER, IW .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (09) :1079-1086